These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8222976)

  • 1. [Identification of latent HBV infection in primary hepatic carcinoma and liver cirrhosis with polymerase chain reaction].
    Yang JM; Liu WW
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):152-4. PubMed ID: 8222976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
    Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
    Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of hepatitis B virus DNA in serum of patients with hepatoma.
    Lie-Injo LE; Lopez CG; Latu J; Lim ML; Balasegaram M
    Cytobios; 1987; 50(201):101-6. PubMed ID: 3036422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus DNA detected by PCR in sera and liver tissues of Chinese patients with chronic liver diseases.
    Zhang YY; Guo LS; Li L; Zhang YD; Hao LJ; Hansson BG; Nordenfelt E
    Chin Med J (Engl); 1993 Jan; 106(1):7-12. PubMed ID: 8504690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
    Song Y; Pan W; Fan Z; Du P; Qi Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of HBV, HCV and HDV serum markers in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC)].
    Zeng WZ; Chu RJ; Jiang MD
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):167-9. PubMed ID: 8222980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of serum hepatitis B virus DNA in patients with various chronic liver diseases].
    Zhou Z; Liu C; Yang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):129-32. PubMed ID: 12515189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
    Shiota G; Oyama K; Udagawa A; Nomi T; Tanaka K; Tsutsumi A; Noguchi N; Okano J; Kishimoto Y; Kanbe T; Kishimoto H; Kawasaki H
    Hepatogastroenterology; 2009; 56(94-95):1516-20. PubMed ID: 19950820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction].
    Xu B; Yao G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):117-20. PubMed ID: 15619813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases.
    Leung NW; Tam JS; Lau GT; Leung TW; Lau WY; Li AK
    Cancer; 1994 Feb; 73(4):1143-8. PubMed ID: 8313316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus DNA in patients with HBsAg in south western Nigeria.
    Odaibo GN; Ola SO; Olaleye OD
    J Med Virol; 2013 Feb; 85(2):214-8. PubMed ID: 23161583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of HBV infection in HBsAg-negative chronic active hepatitis with polymerase chain reaction].
    Luo KX; Zhou R; Liang ZS
    Zhonghua Nei Ke Za Zhi; 1991 Jan; 30(1):21-3, 60. PubMed ID: 2032490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.